Intestine and Lower Gastrointestinal Tract · 2 July 2024

Robotic vs. Laparoscopic Total Mesorectal Excision: Superior 5-Year Survival

Robotic total mesorectal excisions show higher 5-year overall survival rates and comparable long-term oncological outcomes compared to laparoscopic approach for rectal cancer. Additionally, robotic surgery results in lower conversion rates, shorter hospital stays, and fewer postoperative complications. This study suggests robotic surgery as a safe and favorable alternative to traditional approaches for rectal cancer treatment, based on analysis of 594 patients over an 8-year period.

Journal Article by Duhoky R, Rutgers MLW (…) Khan JS et 5 al. in Ann Surg Open

read the whole article in Ann Surg Open

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

More in Intestine and Lower Gastrointestinal Tract

The latest stitches

Lancet4 Nov 2026

Colorectal cancer: shorter chemo, fewer side effects

A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.

Br J Surg4 Nov 2026

Robot matches laparoscopy for rectal cancer survival

Five years after surgery for low rectal cancer, patients operated on robotically did as well as those operated on laparoscopically, according to a randomized trial from three Korean centres.

Ann Surg Oncol2 Nov 2026

Smoking linked to weaker rectal cancer response

Patients smoking at diagnosis were less likely to have a favorable response to treatment before rectal cancer surgery; former smokers were not.

All papers in Intestine and Lower Gastrointestinal Tract →